Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LutrePulse via OmniPod for Ovulation Induction
NCT01976728Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Apr 2014
- Primary completion
- Feb 2018
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of gonadorelin in hypogonadotropic hypogonadism (HH), sponsored by Ferring Pharmaceuticals. Started Apr 2014; status: completed.
02
Drugs
gonadorelin
03
Conditions
hypogonadotropic hypogonadism (HH)
Beyond the preview
Go deeper on NCT01976728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01976728.